Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Stock indices move when expectations and data shift; factors like economic data, earnings, and policy news all influence daily movements, shaping market direction.
27,810 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
SpaceX hits the public markets with a high-profile IPO, but the spacex president warning investors message underscore...
Palantir stock drifted lower again in 2026 after Wolfe Research moved the stock to a neutral stance. The move comes a...
Could a SpaceX and Tesla merger reshape the future of tech and energy? This guide breaks down the potential benefits,...
July could bring a fresh wave of stock gains. This article highlights three stocks likely to lead a rally, with clear...
A new Fed chair promises reform, but progress stalls. This article explains the investing implications when it's been...
A bold claim from a top energy chief has investors reassessing risk. This guide breaks down what a tight oil market c...
As GoodRx navigates evolving discount dynamics and a changing membership model, the 2025 earnings picture will hinge ...
The Ethereum Foundation has begun staking ETH as part of a new treasury plan, coinciding with sales from Ethereum co-...
As 2025 unfolds, investors weigh the promise and pitfalls of ADMA Biologics. This guide breaks down earnings drivers,...
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Nvidia is facing a mixed start to 2026, but the long-term case remains intact. This article explains why a 40% jump b...